Distributor relationships are being explored in the Middle East and North Africa. Ritu Baral, Analyst, TD Cowen: We’re going to go ahead and get started. Thank you very much for joining us for ...

Distributor relationships are being explored in the Middle East and North Africa. Ritu Baral, Analyst, TD Cowen: We’re going to go ahead and get started. Thank you very much for joining us for the ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Vera Therapeutics (VERA – Research Report), with a price target ...

TD Cowen analyst Ritu Baral maintained a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report) today and set a price target of ...

Operator Ladies and gentlemen, thank you for standing by, and welcome to the COMPASS Pathways Limited fourth quarter 2024 investor call. [Operator instructions] I will now hand today's call over to ...

Ritu Baral, TD Cowen: Questioned the impact of Medicare's new catastrophic coverage rules. Management explained adjustments to gross-to-net projections, emphasizing a strategic focus on seamless ...

Ritu Baral, TD Cowen: Inquired about pricing and patient access in Europe. Krish Krishnan explained that Germany launches with the U.S. price for six months, followed by pricing negotiations ...

We'll go to the next question. Your next question is from the line of Ritu Baral with TD Cowen. Thanks, Ritu. So no. To be clear, with the six-week data, we are not going to be getting any ...